BLK vs CPHI · P/E 27, rev $24.22B vs rev $4.5M
BlackRock Inc (BLK) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
BLK currently screens at market cap $172.19B and trailing P/E 26.6. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the BLK and CPHI stock pages for the full models.
Not investment advice.